A detailed history of Central Bank & Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Central Bank & Trust CO holds 14,211 shares of ABT stock, worth $1.65 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
14,211
Previous 14,441 1.59%
Holding current value
$1.65 Million
Previous $1.5 Million 8.0%
% of portfolio
0.23%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $23,016 - $27,169
-230 Reduced 1.59%
14,211 $1.62 Million
Q2 2024

Jul 19, 2024

BUY
$100.73 - $112.44 $235,909 - $263,334
2,342 Added 19.36%
14,441 $1.5 Million
Q1 2024

Apr 11, 2024

BUY
$109.52 - $120.96 $15,661 - $17,297
143 Added 1.2%
12,099 $1.38 Million
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $268,585 - $328,771
2,978 Added 33.17%
11,956 $1.32 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $39,836 - $47,796
417 Added 4.87%
8,978 $869,000
Q2 2023

Jul 13, 2023

SELL
$100.78 - $112.29 $5,341 - $5,951
-53 Reduced 0.62%
8,561 $933,000
Q1 2023

Apr 13, 2023

SELL
$96.86 - $114.01 $15,400 - $18,127
-159 Reduced 1.81%
8,614 $872,000
Q4 2022

Jan 18, 2023

BUY
$95.06 - $111.52 $13,403 - $15,724
141 Added 1.63%
8,773 $0
Q3 2022

Oct 20, 2022

BUY
$96.76 - $112.03 $424,389 - $491,363
4,386 Added 103.3%
8,632 $835,000
Q2 2022

Jul 22, 2022

BUY
$102.07 - $123.37 $292,634 - $353,701
2,867 Added 207.9%
4,246 $461,000
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $80,498 - $98,162
706 Added 104.9%
1,379 $163,000
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $6,532 - $7,227
56 Added 9.08%
673 $80,000
Q2 2021

Jul 16, 2021

SELL
$105.79 - $124.53 $26,764 - $31,506
-253 Reduced 29.08%
617 $72,000
Q1 2021

Apr 20, 2021

SELL
$108.84 - $128.23 $761,771 - $897,481
-6,999 Reduced 88.94%
870 $104,000
Q4 2020

Jan 12, 2021

SELL
$105.0 - $114.42 $19,320 - $21,053
-184 Reduced 2.28%
7,869 $862,000
Q3 2020

Oct 08, 2020

BUY
$91.64 - $111.29 $91 - $111
1 Added 0.01%
8,053 $876,000
Q2 2020

Jul 15, 2020

BUY
$76.57 - $98.0 $258,883 - $331,338
3,381 Added 72.38%
8,052 $736,000
Q1 2020

Apr 14, 2020

SELL
$62.82 - $91.86 $60,935 - $89,104
-970 Reduced 17.2%
4,671 $393,000
Q1 2020

Apr 14, 2020

SELL
$62.82 - $91.86 $27,892 - $40,785
-444 Reduced 7.3%
5,641 $445,000
Q4 2019

Jan 13, 2020

BUY
$78.51 - $87.4 $83,613 - $93,081
1,065 Added 21.22%
6,085 $529,000
Q3 2019

Oct 23, 2019

BUY
$81.84 - $88.74 $28,562 - $30,970
349 Added 7.47%
5,020 $420,000
Q2 2019

Jul 16, 2019

SELL
$72.88 - $85.0 $47,882 - $55,845
-657 Reduced 12.33%
4,671 $393,000
Q1 2019

Apr 22, 2019

SELL
$66.22 - $80.06 $369,640 - $446,894
-5,582 Reduced 51.16%
5,328 $426,000
Q4 2018

Jan 17, 2019

SELL
$65.56 - $74.27 $66,215 - $75,012
-1,010 Reduced 8.47%
10,910 $789,000
Q3 2018

Nov 23, 2018

BUY
$60.81 - $73.36 $38,614 - $46,583
635 Added 5.63%
11,920 $874,000
Q2 2018

Jul 17, 2018

BUY
$57.57 - $63.54 $175,876 - $194,114
3,055 Added 37.12%
11,285 $688,000
Q1 2018

Apr 27, 2018

BUY
$56.27 - $63.62 $92,001 - $104,018
1,635 Added 24.79%
8,230 $493,000
Q4 2017

Jan 16, 2018

BUY
$53.68 - $57.47 $255,624 - $273,672
4,762 Added 259.79%
6,595 $376,000
Q3 2017

Oct 13, 2017

BUY
$48.06 - $53.64 $88,093 - $98,322
1,833
1,833 $98,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Central Bank & Trust CO Portfolio

Follow Central Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.